Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 6/20 | 0.57 |
| ▸ | EGFR | P00533 | 2/20 | 0.50 |
| ▸ | DHFR | P00374 | 2/20 | 0.49 |
| ▸ | WHR1 | P49842 | 1/20 | 0.47 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.44 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.44 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | NQO2 | P16083 | 1/20 | 0.41 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.41 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7799376 | 0.90 | ADORA2A (0.51) | ADORA2AEGFRDHFRWHR1SLC2A1 | |
| SCHEMBL7799233 | 0.85 | ADORA2A (0.62) | ADORA2AEGFRDHFRWHR1HSP90AA1 | |
| SCHEMBL7791033 | 0.84 | ADORA2A (0.61) | ADORA2AEGFRDHFRWHR1HSP90AA1 | |
| SCHEMBL7791023 | 0.84 | ADORA2A (0.57) | ADORA2AEGFRDHFRWHR1HSP90AA1 | |
| SCHEMBL7800422 | 0.84 | ADORA2A (0.57) | ADORA2AEGFRDHFRWHR1HSP90AA1 | |
| SCHEMBL7585771 | 0.84 | ADORA2A (0.57) | ADORA2AEGFRDHFRWHR1HSP90AA1 | |
| SCHEMBL28594419 | 0.83 | EGFR (0.45) | ADORA2AEGFRDHFRWHR1SLC2A1 | |
| SCHEMBL7799250 | 0.81 | ADORA2A (0.53) | ADORA2AEGFRDHFRWHR1HSP90AA1 | |
| SCHEMBL30759714 | 0.80 | WHR1 (0.71) | ADORA2AEGFRDHFRWHR1ADORA1 | |
| SCHEMBL1257435 | 0.80 | WHR1 (0.71) | ADORA2AEGFRDHFRWHR1ADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1163228-A1 | QUINAZOLINES AND THERAPEUTIC USE THEREOF | Parker Hughes Institute (US) | 2001-12-19 | — | — | EP | disclosed |
| EP-1162974-A1 | QUINAZOLINE FORMULATIONS AND THERAPEUTIC USE THEREOF | Parker Hughes Institute (US) | 2001-12-19 | — | — | EP | disclosed |
| US-6316454-B1 | 6,7-Dimethoxy-4-anilinoquinazolines | PARKER HUGHES INSTITUTE | 2001-11-13 | — | — | US | disclosed |
| WO-2000056338-A1 | QUINAZOLINE FORMULATIONS AND THERAPEUTIC USE THEREOF | PARKER HUGHES INSTITUTE (US) | 2000-09-28 | — | — | WO | disclosed |
| WO-2000056720-A1 | QUINAZOLINES AND THERAPEUTIC USE THEREOF | PARKER HUGHES INSTITUTE (US) | 2000-09-28 | — | — | WO | disclosed |